Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.
Stein A, Glockzin G, Wienke A, Arnold D, Edelmann T, Hildebrandt B, Hollerbach S, Illerhaus G, Königsrainer A, Richter M, Schlitt HJ, Schmoll HJ. Stein A, et al. Among authors: wienke a. BMC Cancer. 2012 Aug 16;12:356. doi: 10.1186/1471-2407-12-356. BMC Cancer. 2012. PMID: 22897915 Free PMC article. Review.
Prophylactic nimodipine treatment for cochlear and facial nerve preservation after vestibular schwannoma surgery: a randomized multicenter Phase III trial.
Scheller C, Wienke A, Tatagiba M, Gharabaghi A, Ramina KF, Ganslandt O, Bischoff B, Zenk J, Engelhorn T, Matthies C, Westermaier T, Antoniadis G, Pedro MT, Rohde V, von Eckardstein K, Kretschmer T, Kornhuber M, Steighardt J, Richter M, Barker FG 2nd, Strauss C. Scheller C, et al. Among authors: wienke a. J Neurosurg. 2016 Mar;124(3):657-64. doi: 10.3171/2015.1.JNS142001. Epub 2015 Aug 14. J Neurosurg. 2016. PMID: 26274985 Clinical Trial.
Prophylactic nimodipine treatment and improvement in hearing outcome after vestibular schwannoma surgery: a combined analysis of a randomized, multicenter, Phase III trial and its pilot study.
Scheller C, Wienke A, Tatagiba M, Gharabaghi A, Ramina KF, Ganslandt O, Bischoff B, Zenk J, Engelhorn T, Matthies C, Westermaier T, Antoniadis G, Pedro MT, Rohde V, von Eckardstein K, Kretschmer T, Kornhuber M, Steighardt J, Richter M, Barker FG 2nd, Strauss C. Scheller C, et al. Among authors: wienke a. J Neurosurg. 2017 Dec;127(6):1376-1383. doi: 10.3171/2016.8.JNS16626. Epub 2017 Feb 24. J Neurosurg. 2017. PMID: 28298021 Clinical Trial.
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
Rot S, Kaune T, Taubert H, Greither T, Kotrba J, Güttler A, Wichmann H, Bilkenroth U, Wienke A, Al-Nawas B, Bache M, Vordermark D, Wickenhauser C, Bethmann D, Eckert AW, Kappler M. Rot S, et al. Among authors: wienke a. BMC Cancer. 2019 Feb 15;19(1):155. doi: 10.1186/s12885-019-5327-8. BMC Cancer. 2019. PMID: 30770730 Free PMC article.
570 results